Literature DB >> 26622887

Occupational type affects the receipt of breast cancer adjuvant chemotherapy in China.

Zhengzhi Zhu1, Qiang Huo2, Shengying Wang3, Qifeng Yang2.   

Abstract

Adjuvant chemotherapy has been demonstrated to improve the prognosis of patients with early-stage breast cancer; however, the high cost and side effects associated with this treatment may discourage patients from receiving it. The present study assessed the candidate factors that may influence decisions regarding postoperative adjuvant chemotherapy in females with early-stage breast cancer. Patients diagnosed with invasive breast cancer between January 2000 and December 2007 were enrolled in the study. Information about the patients, including socio-demographic factors, clinicopathological characteristics and receipt of adjuvant chemotherapy, was obtained from their medical records. Overall, 434 out of 1,296 (33.5%) patients with breast cancer decided against receiving adjuvant chemotherapy. Receipt of chemotherapy was significantly associated with the age of the patient at the time of diagnosis (P=0.029), occupational type (P=0.023), and lymph node status (P<0.001). Moderate associations were also observed between receipt of adjuvant chemotherapy and the patients family history of cancer (P=0.055) and hormone-receptor status (P=0.075). The results of the present study suggest that the occupational type of the patient is associated with receipt of adjuvant chemotherapy in China. This observation may provide a novel strategy for physicians to improve patients compliance regarding adjuvant chemotherapy. Further studies in additional developing countries are required in order to validate these observations.

Entities:  

Keywords:  adjuvant chemotherapy; breast cancer; epidemiology; occupational types; retrospective study

Year:  2015        PMID: 26622887      PMCID: PMC4580072          DOI: 10.3892/ol.2015.3571

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

Review 1.  NIH consensus conference. Treatment of early-stage breast cancer.

Authors: 
Journal:  JAMA       Date:  1991-01-16       Impact factor: 56.272

2.  Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data.

Authors:  X Du; J S Goodwin
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

Review 3.  Strategy for detection of cancer hazards to man.

Authors:  R Doll
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

4.  Rural-urban disparities of breast cancer patients in China.

Authors:  Yan Zhang; Yulan Bu; Hua Gao
Journal:  Med Oncol       Date:  2012-12-29       Impact factor: 3.064

Review 5.  Adjuvant endocrine therapy for breast cancer.

Authors:  Ruta D Rao; Melody A Cobleigh
Journal:  Oncology (Williston Park)       Date:  2012-06       Impact factor: 2.990

6.  Pathologic findings from the National Surgical Adjuvant Breast Project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation.

Authors:  E R Fisher; C Redmond; B Fisher
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

7.  Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients.

Authors:  R A Silliman; E Guadagnoli; A B Weitberg; V Mor
Journal:  J Gerontol       Date:  1989-03

8.  Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer.

Authors:  Xianglin L Du; Charles R Key; Cynthia Osborne; Jonathan D Mahnken; James S Goodwin
Journal:  Ann Intern Med       Date:  2003-01-21       Impact factor: 25.391

9.  Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity.

Authors:  Irit Ben-Aharon; Israel Meizner; Tal Granot; Shiri Uri; Noa Hasky; Shulamith Rizel; Rinat Yerushalmi; Aaron Sulkes; Salomon M Stemmer
Journal:  Oncologist       Date:  2012-09-06

10.  Factors associated with receipt of adjuvant chemotherapy among married women with breast cancer.

Authors:  Yan Zhang; Hua Gao; Yulan Bu; Xiuzhen Fan; Jihui Jia
Journal:  World J Surg Oncol       Date:  2013-10-31       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.